CN1222298C - Medicine for treating cardiovascular disease - Google Patents
Medicine for treating cardiovascular disease Download PDFInfo
- Publication number
- CN1222298C CN1222298C CN 01129552 CN01129552A CN1222298C CN 1222298 C CN1222298 C CN 1222298C CN 01129552 CN01129552 CN 01129552 CN 01129552 A CN01129552 A CN 01129552A CN 1222298 C CN1222298 C CN 1222298C
- Authority
- CN
- China
- Prior art keywords
- radix
- medicine
- grams
- cardiovascular diseases
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The present invention relates to a medicine for treating cardiovascular diseases, which is prepared from 28 Chinese herbal medicines comprising barbary wolfberry fruit, polygonatum, lepidium, radix notoginseng, coloed mistletoe herb, etc. The medicine has obvious effects on cardiovascular diseases, such as coronary diseases, mild heart failure, high blood pressure type heart diseases, viral myocarditis, myocardial infarction, etc., and can improve immunity and prevent senility. The medicine has the advantages of simple production process, low cost, wide range of treatment, immediate effect, lasting action, no toxic or side effect and no medicine resistance.
Description
The present invention relates to a kind of cardiovascular diseases's of treatment medicine.It specifically is the Chinese patent medicine of feedstock production with the Chinese herbal medicine.
Show in the investigation of different times according to China hygiene department: cardiovascular diseases's M ﹠ M all is higher than other internal disease.(drawing national higher education medical science undergraduate course teaching material " internal medicine " preface) from front page in 1984.
The Chinese patent medicine of producing in batches though obtained certain curative effect, only takes stopgap measures on the treatment cardiovascular diseases at present, can not fundamentally treat and improve; Coronary heart disease and arteriosclerosis cause: all diseases such as angina pectoris, hypertension, myocardial ischemia, arrhythmia and myocardial infarction.Chinese patent medicine commonly used has FUFANG DANSHEN PIAN, Radix Salviae Miltiorrhizae drop pill, storax pill for treating coronary heart disease, pills for curing heart disease etc.These medicines are low to cardiovascular diseases's cure rate, the course of treatment long, price is also higher.
The object of the present invention is to provide that a kind of to have the treatment cardiovascular disease in extensive range, cure height and short treating period, the treatment cardiovascular diseases's that safety has no side effect Chinese patent medicine is to remedy the deficiency of other patent medicine in above-mentioned technology.
Technical scheme of the present invention be pharmaceutical formulation than being substantially: Radix Adenophorae 25, Rhizoma Polygonati Odorati 25, Semen Lepidii (Semen Descurainiae) 20, Radix Salviae Miltiorrhizae 20, Fructus Schisandrae Chinensis 9-15, Radix Puerariae 15, Lignum Dalbergiae Odoriferae 3-6, Radix Sophorae Flavescentis 8-15, Styrax 1-3, Borneolum Syntheticum 1-3, Radix Curcumae 15, Bulbus Lilii 15, Radix Scutellariae 6-10, Fructus Forsythiae 15-20, Radix Codonopsis 15, Rhizoma Acori Graminei 10, Herba Visci 15-20, Plumula Nelumbinis 15-20, Cortex Moutan 15-18, Radix Notoginseng 15-18, Radix Ginseng 15, Bulbus Allii Macrostemonis 5-10, the Flos Sophorae Immaturus 10, the Radix Astragali 20, Herba Epimedii 15, Fructus Crataegi 20, Radix Paeoniae Rubra 10.
It is characterized in that it is made up of the component of following weight proportioning: Radix Adenophorae 25, Rhizoma Polygonati Odorati 25, Semen Lepidii (Semen Descurainiae) 20, Radix Salviae Miltiorrhizae 20, Fructus Schisandrae Chinensis 10-15, Radix Puerariae 15, Lignum Dalbergiae Odoriferae 5-8, Radix Sophorae Flavescentis 10-15, Styrax 1-3, Borneolum Syntheticum 1-3, Radix Curcumae 15, Bulbus Lilii 15, Radix Scutellariae 8-10, Fructus Forsythiae 20, Radix Codonopsis 15, Rhizoma Acori Graminei 12, Herba Visci 15-20, Plumula Nelumbinis 15-20, Cortex Moutan 15-18, Radix Notoginseng 15-20, Radix Ginseng 15, Bulbus Allii Macrostemonis 5-10, Radix Angelicae Sinensis 15, the Flos Sophorae Immaturus 10, Radix Astragali 20-25, Herba Epimedii 15, Fructus Crataegi 20, Radix Paeoniae Rubra 10.
Its best proportioning is Radix Adenophorae 25, Radix Puerariae 15, Lignum Dalbergiae Odoriferae 15-8, Radix Sophorae Flavescentis 10,15, Styrax 1-3, Borneolum Syntheticum 1-3, Radix Curcumae 15, Bulbus Lilii 15, Radix Scutellariae 8-10, Fructus Forsythiae 20, Radix Codonopsis 15, Rhizoma Acori Graminei 12, Herba Visci 15-20, Plumula Nelumbinis 20, Cortex Moutan 15-18, Radix Notoginseng 15-20, Radix Ginseng 15, Bulbus Allii Macrostemonis 5-10, the Flos Sophorae Immaturus 10, Radix Astragali 20-25, Herba Epimedii 15, Fructus Crataegi 20, Radix Paeoniae Rubra 10.
Medication preparation process of the present invention is: 20 Six-element Chinese medicines except that Styrax, Borneolum Syntheticum are got the raw materials ready by the prescription proportioning, be ground into 120 order fine powders, Styrax, Borneolum Syntheticum by prescription than independent porphyrize, after other 20 Six-element medicated powder fully mixed, the zero capsule of packing into was done routine disinfection through ultraviolet radiation and is made capsule.
Solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of motherland's medical science to the cardiovascular diseases, with reference to the modern pharmacological research achievement, from the Chinese herbal medicine treasure-house, select Radix Adenophorae, Rhizoma Polygonati Odorati, Radix Notoginseng, Semen Lepidii (Semen Descurainiae), Radix Puerariae, Radix Salviae Miltiorrhizae, Cortex Moutan and share, have the effect of nourishing YIN and clearing away heat, blood circulation promoting and blood stasis dispelling, inducing diuresis to remove edema.Modern pharmacology proof Radix Adenophorae, Rhizoma Polygonati Odorati, Semen Lepidii (Semen Descurainiae), Radix Puerariae, Radix Notoginseng all are rich in the heart tonifying composition, the increase of myocardial contraction amplitude, contractility are strengthened, and can strengthen and regulate myocardial cell and the arteriolar energy metabolism of heart, increase the whenever rich output decreased heart rate of heart, improve the activity of myocardium high superoxide dismutase, alleviate the myocardial infarction program, quicken the myocardial repair process.(drawing " the up-to-date Pharmacology and Clinics of Chinese Materia Medica application " of publishing in 1999) from the Huaxia Press.Rhizoma Acori Graminei, Lignum Dalbergiae Odoriferae, Radix Sophorae Flavescentis, Radix Scutellariae, Fructus Schisandrae Chinensis, Herba Visci, Plumula Nelumbinis share have that astringing QI is calmed the nerves, the effect of heart fire-clearing upset-relieving, regulating QI to relieve pain.Fructus Forsythiae, Styrax, Borneolum Syntheticum, Bulbus Allii Macrostemonis, Fructus Crataegi, share out breast promoting the circulation of QI, the eliminating stagnation stagnant effect that disappears, modern pharmacological research proves: above-mentioned two groups of medicines share has coronary blood flow increasing, promote the arteria coronaria collateral circulation, microcirculation improvement, alleviate the formation of atherosclerosis and speckle, significantly reduce the sticking degree of blood and strengthen hematopoietic stem cell quantity, various arrhythmia are all had different antagonisms.(drawing) from " Chinese medicine voluminous dictionary " and " up-to-date Pharmacology and Clinics of Chinese Materia Medica application ".Radix Codonopsis, the Radix Astragali, Radix Angelicae Sinensis, Radix Ginseng, Herba Epimedii, Bulbus Lilii, the Flos Sophorae Immaturus, Radix Curcumae, Radix Paeoniae Rubra share have benefiting qi and nourishing blood, the effect of vital base and primordial QI consolidating, removing heat from blood promoting the circulation of blood.Modern pharmacological research proves, medicine-feeding is share has dual regulation to blood pressure, and expansible vascular smooth muscle, fall to blood vessel exopathogenic factor resistance, and can improve brain, kidney function, improve immunity, can directly destroy endotoxin, be used for the treatment of syndrome after the myocardial infarction.(drawing) from " up-to-date Pharmacology and Clinics of Chinese Materia Medica application ".
The present invention treats coronary heart disease, hypertension, heart disease, arteriosclerosis, acute and chronic heart failure (refractory type heart failure DeGrain).Various cardiovascular diseasess such as viral myocarditis, pericarditis, lung heart syndrome, rheumatic heart disease all have significant curative effect.Can eliminate at short notice, because the cardiovascular diseases causes: symptoms such as dyspnea, cardiopalmus, insomnia, headache, dizzy, edema, cyanosis, cough, oliguria.
The present invention has that production technology is simple, cost is low, therapeutic domain is extensive, and curative effect lasting stability, effect be fast, have no side effect, and advantage such as do not develop immunity to drugs.
The present invention can be made into capsule adult dose, is generally every day twice, each six grams, and maximum dose is multiplicable.
Embodiment: get Radix Adenophorae 25 grams, Rhizoma Polygonati Odorati 25 grams, Semen Lepidii (Semen Descurainiae) 20 grams, Radix Salviae Miltiorrhizae 20 grams, Fructus Schisandrae Chinensis 15 grams, Radix Puerariae 15 grams, Lignum Dalbergiae Odoriferae 6 grams, Radix Sophorae Flavescentis 10 grams, Styrax 3 grams, Borneolum Syntheticum 3 grams, Radix Curcumae 15 grams, Bulbus Lilii 15 grams, Radix Scutellariae 10 grams, Fructus Forsythiae 20 grams, Radix Codonopsis 15 grams, Rhizoma Acori Graminei 12 grams, Herba Visci 20 grams, Plumula Nelumbinis 20 grams, Cortex Moutan 15 grams, Radix Notoginseng 15 grams, Radix Ginseng 15 grams, Bulbus Allii Macrostemonis 10 grams, the Flos Sophorae Immaturus 10 grams, the Radix Astragali 20 grams, Herba Epimedii 15 grams, Radix Paeoniae Rubra 10 grams, with Styrax, the powder that Borneolum Syntheticum two flavors singly are ground into is standby; It is encapsulated that other 26 flavor Chinese medicine powder becomes 120 order fine powders and Styrax, Borneolum Syntheticum fully to mix, and every heavy 1 gram gets final product through ultraviolet radiation disinfection.
Case one:, 51 years old, suffer from arteriosclerosis, coronary heart disease, hypertension for many years, paroxysmal angina pectoris, headache, dizzy, dyspnea, all symptoms, moving slightly aggravation in X woman.This clothes storax pill for treating coronary heart disease, Radix Salviae Miltiorrhizae Tabellae are not obtained desirable curative effect, change twice of 10 day every day of clothes medicine of the present invention (early after ante cibum, the supper), the obviously continuous clothes of each 6 gram effects 30 days, and all transference cures, and can join various motions, follow up a case by regular visits to and do not see recurrence so far.
Case two: the XX of the Qin, the man, 54 years old, first visit through looking into, was diagnosed as coronary heart disease for burst cardiogenic shock, angina pectoris, and electrocardiogram shows its rhythm of the heart severe disorder, through hospitalization, does not see produce effects.Gone out to observe treatment and once taken, FUFANG DANSHEN PIAN, patent medicine such as the comfortable ball of regulating the flow of vital energy all do not have positive effect, only make short-term with the clothes nitroglycerin and alleviate.Through clothes medicine of the present invention, every day twice, each 6 grams, because of being that all diseases all obviously alleviate, continued clothes 45 days, not anti-symptom is eliminated, and electrocardiogram shows to be treated normally, follows up a case by regular visits to and does not see recurrence half a year.
Claims (1)
1, a kind of medicine for the treatment of the cardiovascular diseases is characterized in that it is made up of the component of following weight proportioning: Radix Adenophorae 25, Rhizoma Polygonati Odorati 25, Semen Lepidii (Semen Descurainiae) 20, Radix Salviae Miltiorrhizae 20, Fructus Schisandrae Chinensis 10-15, Radix Puerariae 15, Lignum Dalbergiae Odoriferae 5-8, Radix Sophorae Flavescentis 10-15, Styrax 1-3, Borneolum Syntheticum 1-3, Radix Curcumae 15, Bulbus Lilii 15, Radix Scutellariae 8-10, Fructus Forsythiae 20, Radix Codonopsis 15, Rhizoma Acori Graminei 12, Herba Visci 15-20, Plumula Nelumbinis 15-20, Cortex Moutan 15-18, Radix Notoginseng 15-20, Radix Ginseng 15, Bulbus Allii Macrostemonis 5-10, Radix Angelicae Sinensis 15, the Flos Sophorae Immaturus 10, Radix Astragali 20-25, Herba Epimedii 15, Fructus Crataegi 20, Radix Paeoniae Rubra 10.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01129552 CN1222298C (en) | 2001-06-26 | 2001-06-26 | Medicine for treating cardiovascular disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01129552 CN1222298C (en) | 2001-06-26 | 2001-06-26 | Medicine for treating cardiovascular disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1393257A CN1393257A (en) | 2003-01-29 |
| CN1222298C true CN1222298C (en) | 2005-10-12 |
Family
ID=4669266
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01129552 Expired - Fee Related CN1222298C (en) | 2001-06-26 | 2001-06-26 | Medicine for treating cardiovascular disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1222298C (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE602004015219D1 (en) * | 2003-04-29 | 2008-09-04 | Li Min Pharmaceutical Factory | COMPOSITION WITH RADIX CODONOPSIS PILOSULAE AND RADIX ASTRAGALI FOR THE TREATMENT OF ACUTE LUNG INJURY |
| CN1327845C (en) * | 2004-10-19 | 2007-07-25 | 哈尔滨医科大学 | Chinese medicine for treating cardiovascular and cerebrovascular disease |
| CN100441212C (en) * | 2005-01-12 | 2008-12-10 | 王振球 | Chinese medicine for treating cardiac failure |
| CN100430068C (en) * | 2005-01-22 | 2008-11-05 | 张明伦 | Chinese medicine for treating cardiomyopathy |
| CN1311847C (en) * | 2005-10-27 | 2007-04-25 | 杨文琳 | Hypertension treating medicine |
| CN101085064B (en) * | 2006-06-08 | 2012-07-04 | 天津天士力制药股份有限公司 | Composition containing radix paeoniae rubrathe for treating cardiovascular diseases and its preparation |
| CN101530556B (en) * | 2009-04-17 | 2011-05-11 | 河北惟祥福中药科技开发有限公司 | Chinese traditional medicine preparation used for curing angina |
| CN101647941B (en) * | 2009-09-23 | 2012-01-11 | 苏州派腾生物医药科技有限公司 | Composition for treating ischemic heart disease and preparation method thereof |
| CN103142941B (en) * | 2012-03-31 | 2014-07-23 | 陈欣 | Traditional Chinese medicine composition capsule for treating myocardial infarction and preparation method thereof |
| CN102631538B (en) * | 2012-04-20 | 2014-01-15 | 蔡惠磊 | Traditional Chinese medicine for treating heart disease |
| CN103768505A (en) * | 2012-10-18 | 2014-05-07 | 李恩超 | Traditional Chinese medicine composition for treating hypertension |
| CN103316286A (en) * | 2013-05-23 | 2013-09-25 | 太仓市胜舟生物技术有限公司 | Application of medicine in treatment stent post-operation angiogenesis promoting medicines |
| CN103316287A (en) * | 2013-05-23 | 2013-09-25 | 太仓市胜舟生物技术有限公司 | Application of traditional Chinese medicinal composition in preparation of treatment stent post-operation angiogenesis promoting medicines |
| CN103720870B (en) * | 2014-01-11 | 2015-02-25 | 徐绍敏 | Traditional Chinese medicament preparation for treating myocarditis and preparation method thereof |
| CN112755114A (en) * | 2021-03-19 | 2021-05-07 | 漳州卫生职业学院 | Pharmaceutical composition for acute myocardial infarction |
-
2001
- 2001-06-26 CN CN 01129552 patent/CN1222298C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1393257A (en) | 2003-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1222298C (en) | Medicine for treating cardiovascular disease | |
| CN100457176C (en) | Chinese medicinal preparation for curriculum of physical and fatigue reducing | |
| CN1994451B (en) | Chinese medicinal composition for treating depression, its preparation method and application | |
| CN102133378A (en) | Medicament for treating breast cancer | |
| CN102172385A (en) | Chinese medicinal preparation with effects of enhancing immunity, lowering blood sugar and lowering blood fat | |
| CN102161961B (en) | Health-care wine and preparation method thereof | |
| CN102284022A (en) | Cough medicament and preparation method thereof | |
| CN101708237A (en) | Medicinal composition used for tonifying qi and invigorating pulse, preparation method thereof and application thereof | |
| CN1356113A (en) | Process for preparing Chinese medicine to treat cardiovascular and cerebrovascular diseases | |
| CN103479691A (en) | Lipid-decreasing liver protection traditional Chinese medicine composition | |
| CN108042766A (en) | A kind of Bushen Tongluo supports brain cream and preparation method thereof | |
| CN1101556A (en) | Embolism clearing powder and its preparation method | |
| CN1199664C (en) | Chinese medicine for treating cardiovascular and cerebrovascular diseases and its preparing process | |
| CN100569263C (en) | A kind of pharmaceutical composition for the treatment of stomachache and preparation method thereof | |
| CN111450192A (en) | A Chinese medicinal composition for treating hypertension, hyperlipidemia and hyperglycemia | |
| CN101757206A (en) | Chinese medicine preparation for treating chronic colitis | |
| CN109876127B (en) | Blood-nourishing angelica sinensis capsule and preparation method thereof | |
| CN1050754C (en) | Supplementing qi detoxicating granule or powder preparation to be taken after being infused in boiling water for children and preparing process thereof | |
| CN1385191A (en) | Medicine for treating liver disease | |
| CN102698131A (en) | Capsule for treating diabetes mellitus | |
| CN111011852A (en) | Preparation method of ginseng instant food with liver protection function | |
| CN111000969A (en) | Pharmaceutical composition for treating simple obesity and preparation method thereof | |
| CN1151813C (en) | Traditional Chinese medicine composition for curing insomnia | |
| CN105125894B (en) | A kind of Chinese medicine composition for treating headache | |
| CN101637565A (en) | Pure Chinese medicinal preparation for treating arrhythmia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Zhang Ying Document name: Notice of publication of application for patent for invention |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C57 | Notification of unclear or unknown address | ||
| DD01 | Delivery of document by public notice |
Addressee: Li Guiqin Document name: Notification of Termination of Patent Right |
|
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20051012 |